Skip to content

Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of T2DM

Effect of Low-Calorie Diet and Lifestyle Intervention on Reversal of Type 2 Diabetes Mellitus, Hepatic and Pancreatic Fat: A Two-year Randomized Control Trial in New Delhi, India

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05925946
Acronym
CURE-DM
Enrollment
60
Registered
2023-06-29
Start date
2023-10-01
Completion date
2026-10-31
Last updated
2023-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Diet Habit, PreDiabetes

Keywords

Type 2 Diabetes, Low calorie diet, Asian Indians, hepatic fat, pancreatic fat

Brief summary

An increase in body fat, even when within the normal BMI range is one of the essential drivers of T2DM in Asian Indians. In this context, the relationship between excess hepatic fat and pancreatic fat appears to be necessary. A low-calorie (high protein and low carb) vegetarian diet with appropriate exercise, in a protocol similar to the DiRECT study, may lead to weight loss, reversal of diabetes, and decrease in ectopic fat.

Detailed description

Diabetes is one of the biggest global public health problems. India has 100 million people living with diabetes as per the 2023 data. Reversal of T2DM, the holy grail of diabetes management, was not deemed possible until recently. Primary care-led weight management for remission of type 2 diabetes (DiRECT) trial has been conducted in obese patients with T2DM patients for a period of 2 years in the UK. Research on the effect of dietary intervention would be necessary for Asian Indians since liver fat deposition is more severe than in white Caucasians. Although some nutritionists and physicians are replicating methods of DiRECT study in their patients, it is not clear if similar diets will work effectively in community-dwelling Asian Indians.

Interventions

DIETARY_SUPPLEMENTCURE-DM

1. This randomized controlled prospective trial will be of 2 years duration where 150 patients with T2DM from urban areas of Delhi will be screened. 2. These subjects will be randomized into two groups by computer-generated randomization list using variable block size. 3. Group A (n, 60, test group)will be received a low-calorie diet along with appropriate exercise counseling; and group B (n, 60, Control group) will be received balanced diet along with exercise advice.

Sponsors

Ministry of Science and Technology, India
CollaboratorOTHER_GOV
Diabetes Foundation, India
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with T2DM within the previous 3 years * Age 20-65 years * BMI \>25-45kg/m2 * HbA1c\> 6.5% at baseline (on current treatment, if any)

Exclusion criteria

* Recent or screening HbA1c of 9% or higher * Weight loss of \>5 kg within the previous 6 months * Significant cardiopulmonary * Hepatic, or another endocrine disease * Current participation in any other research drug study in the previous three months * Past history of bariatric surgery Malignancy other than minor skin lesions and Possibility of pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Reversal of diabetes24 MonthsThis randomized controlled prospective trial will be of 2 years duration with T2D. These subjects will be randomized into two groups, Group A (intervention group) will receive a professionally supported low-calorie diet along with appropriate exercise counselling; Group B (Control group) will be receiving encouragement to follow standard diet and exercise advice.

Secondary

MeasureTime frameDescription
Muscle strength24 MonthsHandgrip muscle strength by Jamar Dynamometer
Anthropometric assessment24 MonthsWeight, BMI, circumferences (waist, hip, mid-thigh, mid-arm and neck), skinfold thickness (biceps, triceps, sub scapular, supra-iliac, thigh, lateral thoracic and calf)
Hepatic and Pancreatic Fat24 MonthsLiver and pancreatic fat fraction (proton-density fat fraction-magnetic resonance imaging (PDFF-MRI) and thigh skeletal muscle area (by MRI).
Body fat24 MonthsBody fat will be done by Whole body dual-energy X-ray absorptiometry (DEXA scan
Insulin Resistance24 MonthsSurrogate markers of insulin sensitivity

Contacts

Primary ContactAnoop Misra, MD
anoopmisra@gmail.com01141759672
Backup ContactSurya Prakash, PhD+Post Doc
suryabhat@gmail.com01141759672

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026